BXN — Bioxyne Balance Sheet
0.000.00%
Last trade - 00:00
- AU$15.21m
- AU$13.47m
- AU$5.16m
2019 June 30th | 2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.77 | 1.75 | 1.6 | 0.066 | 3.85 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.779 | 0.318 | 0.364 | 0.253 | 0.936 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.52 | 3.07 | 2.51 | 0.407 | 6.04 |
Net Property, Plant And Equipment | 0.209 | 0.235 | 0.138 | 0.043 | 0.085 |
Net Intangible Assets | |||||
Total Assets | 3.97 | 3.34 | 2.68 | 0.45 | 17.7 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.829 | 0.726 | 0.745 | 0.815 | 2.69 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.882 | 0.779 | 0.798 | 0.815 | 2.56 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.09 | 2.56 | 1.88 | -0.365 | 15.1 |
Total Liabilities & Shareholders' Equity | 3.97 | 3.34 | 2.68 | 0.45 | 17.7 |
Total Common Shares Outstanding |